William Blair analyst Myles Minter downgrades Moderna (NASDAQ:MRNA) from Outperform to Market Perform.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
Alpaca · IEX Real-Time PriceUpdated 12:32 NY
Which Real Estate ETF Is the Better Buy: State Street’s XLRE or Northern Trust’s Global GQRE?
Yahoo37 Minutes Ago
You Can Do Better Than Nike. Buy This High-Yield Dividend Stock Instead.
Yahoo44 Minutes Ago
Chipotle Hit a 52-Week Low Last Week. Here’s What RBC’s Upside Call Needs on October 28
Yahoo53 Minutes Ago
Target wants to win customers, but price cuts miss the mark
Yahoo1 Hour Ago
HCA Healthcare Reports Q3 Adjusted EPS of $7.22, Raises Expectations Within 2026 Guidance Range
Yahoo1 Hour Ago
